HRP20100428T1 - Antibakterijski derivati kvinolina - Google Patents

Antibakterijski derivati kvinolina Download PDF

Info

Publication number
HRP20100428T1
HRP20100428T1 HR20100428T HRP20100428T HRP20100428T1 HR P20100428 T1 HRP20100428 T1 HR P20100428T1 HR 20100428 T HR20100428 T HR 20100428T HR P20100428 T HRP20100428 T HR P20100428T HR P20100428 T1 HRP20100428 T1 HR P20100428T1
Authority
HR
Croatia
Prior art keywords
alkyl
aryl
het
compound according
mono
Prior art date
Application number
HR20100428T
Other languages
English (en)
Croatian (hr)
Inventor
Emile Georges Guillemont J�r�me
Dorange Ismet
Jozef Lodewijk Marcel Andries Koenraad
Koul Anil
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HRP20100428T1 publication Critical patent/HRP20100428T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20100428T 2006-12-06 2007-12-04 Antibakterijski derivati kvinolina HRP20100428T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125546 2006-12-06
PCT/EP2007/063312 WO2008068266A1 (en) 2006-12-06 2007-12-04 Antibacterial quinoline derivatives

Publications (1)

Publication Number Publication Date
HRP20100428T1 true HRP20100428T1 (hr) 2010-09-30

Family

ID=38038656

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100428T HRP20100428T1 (hr) 2006-12-06 2007-12-04 Antibakterijski derivati kvinolina

Country Status (33)

Country Link
US (1) US20100069366A1 (cg-RX-API-DMAC7.html)
EP (1) EP2099762B1 (cg-RX-API-DMAC7.html)
JP (1) JP5356244B2 (cg-RX-API-DMAC7.html)
KR (1) KR101514992B1 (cg-RX-API-DMAC7.html)
CN (1) CN101547907B (cg-RX-API-DMAC7.html)
AP (1) AP2478A (cg-RX-API-DMAC7.html)
AR (1) AR064153A1 (cg-RX-API-DMAC7.html)
AT (1) ATE467619T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007328980B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0719920B8 (cg-RX-API-DMAC7.html)
CA (1) CA2668515C (cg-RX-API-DMAC7.html)
CL (1) CL2007003519A1 (cg-RX-API-DMAC7.html)
CY (1) CY1111188T1 (cg-RX-API-DMAC7.html)
DE (1) DE602007006553D1 (cg-RX-API-DMAC7.html)
DK (1) DK2099762T3 (cg-RX-API-DMAC7.html)
EA (1) EA200970534A1 (cg-RX-API-DMAC7.html)
ES (1) ES2345463T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20100428T1 (cg-RX-API-DMAC7.html)
IL (1) IL199079A (cg-RX-API-DMAC7.html)
JO (1) JO2684B1 (cg-RX-API-DMAC7.html)
ME (1) ME01127B (cg-RX-API-DMAC7.html)
MX (1) MX2009005982A (cg-RX-API-DMAC7.html)
MY (1) MY145924A (cg-RX-API-DMAC7.html)
NO (1) NO341996B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ576863A (cg-RX-API-DMAC7.html)
PL (1) PL2099762T3 (cg-RX-API-DMAC7.html)
PT (1) PT2099762E (cg-RX-API-DMAC7.html)
RS (1) RS51382B (cg-RX-API-DMAC7.html)
SI (1) SI2099762T1 (cg-RX-API-DMAC7.html)
TW (1) TWI484959B (cg-RX-API-DMAC7.html)
UA (1) UA101305C2 (cg-RX-API-DMAC7.html)
WO (1) WO2008068266A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200903947B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5857511B2 (ja) * 2010-08-10 2016-02-10 住友化学株式会社 植物病害防除組成物およびその用途
MX358506B (es) 2012-04-27 2018-08-22 Janssen Pharmaceutica Nv Derivados de quinolina antibacterianos.
EP2841425B1 (en) 2012-04-27 2016-03-23 Janssen Pharmaceutica, N.V. Antibacterial quinoline derivatives
CN105017147B (zh) * 2014-04-30 2019-02-01 中国医学科学院药物研究所 一种回收和利用Bedaquiline立体化学异构体的方法
CN105330595B (zh) * 2014-07-14 2019-12-10 上海嘉坦医药科技有限公司 吡啶衍生物及其作为抗分支杆菌的应用
EP3170810B1 (en) * 2014-07-14 2018-09-19 Cisen Pharmaceutical Co., Ltd. Pyridine derivatives and anti-mycobacterial use thereof
CN108473428B (zh) * 2016-01-13 2021-07-23 上海嘉坦医药科技有限公司 一种吡啶衍生物类化合物的制备方法及其中间体和晶型
ES2934785T3 (es) * 2016-03-07 2023-02-27 Global Alliance For Tb Drug Development Inc Compuestos antibacterianos y usos de los mismos
CN109384716B (zh) * 2017-08-11 2021-06-29 海创药业股份有限公司 一种氘代喹啉化合物及其制备和用途
US20250214980A1 (en) 2022-03-14 2025-07-03 Slap Pharmaceuticals Llc Multicyclic compounds
CN116925723B (zh) * 2022-03-30 2025-04-01 中国石油天然气股份有限公司 油气田用杂环有机硅季铵盐与活性炭共混杀菌剂及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270123A1 (en) * 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
JP4484703B2 (ja) * 2002-07-25 2010-06-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キノリン誘導体およびミコバクテリア抑制剤としてのそれらの使用
PL1711181T3 (pl) * 2004-01-23 2010-02-26 Janssen Pharmaceutica Nv Pochodne chinoliny i ich zastosowanie jako inhibitorów mykobakteryjnych
US7338949B2 (en) * 2004-01-23 2008-03-04 Janssen Pharmaceutica N.V. Mycobacterial inhibitors
EA011572B9 (ru) * 2004-01-29 2018-01-31 Янссен Фармацевтика Н.В. Производные хинолина для применения в качестве микобактериальных ингибиторов
AU2005249231B2 (en) * 2004-05-28 2010-11-11 Janssen Pharmaceutica N.V. Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
EP1677083A1 (fr) * 2004-12-22 2006-07-05 Roxer Industries S.A. Capteur de niveau d'un liquide.
CA2528849C (en) * 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents

Also Published As

Publication number Publication date
AR064153A1 (es) 2009-03-18
NZ576863A (en) 2011-09-30
US20100069366A1 (en) 2010-03-18
CN101547907A (zh) 2009-09-30
ATE467619T1 (de) 2010-05-15
PL2099762T3 (pl) 2010-10-29
PT2099762E (pt) 2010-08-04
CA2668515C (en) 2016-03-29
AP2009004872A0 (en) 2009-06-30
MX2009005982A (es) 2009-06-16
KR20090090360A (ko) 2009-08-25
JP2010511667A (ja) 2010-04-15
MY145924A (en) 2012-05-15
IL199079A (en) 2013-06-27
CL2007003519A1 (es) 2008-07-11
SI2099762T1 (sl) 2010-09-30
EP2099762B1 (en) 2010-05-12
AU2007328980A1 (en) 2008-06-12
JP5356244B2 (ja) 2013-12-04
DE602007006553D1 (de) 2010-06-24
EP2099762A1 (en) 2009-09-16
HK1137441A1 (en) 2010-07-30
JO2684B1 (en) 2013-03-03
ES2345463T3 (es) 2010-09-23
TWI484959B (zh) 2015-05-21
ZA200903947B (en) 2010-08-25
UA101305C2 (ru) 2013-03-25
CN101547907B (zh) 2013-01-02
EA200970534A1 (ru) 2009-10-30
CA2668515A1 (en) 2008-06-12
BRPI0719920A2 (pt) 2014-03-04
RS51382B (sr) 2011-02-28
TW200840575A (en) 2008-10-16
NO20092539L (no) 2009-09-04
BRPI0719920B1 (pt) 2020-08-04
WO2008068266A1 (en) 2008-06-12
BRPI0719920B8 (pt) 2021-05-25
KR101514992B1 (ko) 2015-04-24
NO341996B1 (no) 2018-03-12
ME01127B (me) 2013-03-20
AP2478A (en) 2012-09-27
DK2099762T3 (da) 2010-08-30
CY1111188T1 (el) 2015-06-11
AU2007328980B2 (en) 2013-04-18

Similar Documents

Publication Publication Date Title
HRP20100428T1 (hr) Antibakterijski derivati kvinolina
HRP20160585T1 (hr) Antibakterijski derivati kinolina
JP2010511667A5 (cg-RX-API-DMAC7.html)
HRP20110428T1 (hr) Derivati piperidin-amino-benzimidazola kao inhibitori respiratorne sincitijalne virusne replikacije
RU2009125520A (ru) Антибактериальные хинолиновые производные
HRP20100696T1 (hr) Hiv inhibirajuci 5-(hidroksimetilen i aminometilen) supstituirani pirimidini
HRP20151111T1 (hr) Kinuklidinski spojevi kao ligandi nikotinskog acetilkolin alfa-7 receptora
HRP20131116T1 (hr) Derivati kinolina kao antibakterijska sredstva
HRP20090673T1 (hr) Derivati kvinolina i njihova uporaba kao mikobakterijskih inhibitora
NZ606848A (en) 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (bace)
ES2207010T3 (es) Derivados de oxazolidinona y composiciones farmaceuticas.
HRP20080307T3 (hr) Uporaba supstituiranih kinolinskih derivata za tretman bolesti uzrokovanih mikobakterijama otpornima na lijekove
KR20140085437A (ko) 항균 화합물 및 이의 사용 방법
HRP20170317T1 (hr) Spojevi pirimidin-2-amina i njihova uporaba kao inhibitora jak kinaza
CA2554049A1 (en) Quinoline derivatives for use as mycobacterial inhibitors
CA2846663A1 (en) Antibacterial compounds and methods for use
JP2010511671A5 (cg-RX-API-DMAC7.html)
ES3038757T3 (en) Novel n-acyl-arylsulfonamide derivatives as aminoacyl-trna synthetase inhibitors
RU2009125525A (ru) Антибактериальные производные хинолина
HRP20090439T1 (hr) Supstituirani derivati propenil piperazina kao novi inhibitori histonske deacetilaze
HRP20110024T1 (hr) Antibakterijski derivati kvinolina
JP2010511670A5 (cg-RX-API-DMAC7.html)
IL268967B (en) Azetidine derivative
JP2010511672A5 (cg-RX-API-DMAC7.html)
AR064147A1 (es) Derivados de quinolina antibacterianos